Advertisement

Free Radicals, Oxidative Stress, and Cardiovascular Disease

  • K. Richard Bruckdorfer
Chapter

Abstract

The evolution of cardiovascular disease occurs over many decades and has several phases associated with it. It is a process of two parts, one which involves the development of atherosclerotic plaque and the other the formation of thrombi most typically, but not exclusively, in the later stages of the disease.

Keywords

Atherosclerotic Plaque Dietary Antioxidant Cholesterol Oxide Tyrosyl Residue Peroxynitrous Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049–55.PubMedGoogle Scholar
  2. 2.
    Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev. 2008;88:1243–76.PubMedCrossRefGoogle Scholar
  3. 3.
    Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Oxford University Press; 1999.Google Scholar
  4. 4.
    Matoba T, Shimokawa H, Nakashima M, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2006;106:1521–30.CrossRefGoogle Scholar
  5. 5.
    Bruckdorfer R. The basics about nitric oxide. Mol Aspects Med. 2005;26:3–31.PubMedCrossRefGoogle Scholar
  6. 6.
    Warner HR. Apoptosis: a two-edged sword in aging. Ann N Y Acad Sci. 1999;887:1–11.PubMedCrossRefGoogle Scholar
  7. 7.
    Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural and functional properties of oxidised low-density lipoproteins. Chem Res Toxicol. 1990;3:77–91.PubMedCrossRefGoogle Scholar
  8. 8.
    Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 1983;3:149–59.PubMedCrossRefGoogle Scholar
  9. 9.
    Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;25:1102–11.PubMedCrossRefGoogle Scholar
  10. 10.
    Nicholls SJ, Zheng L, Hazen SL. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med. 2005;15:212–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Vadseth C, Souza JM, Thomson L, et al. Pro-thrombotic state induced by post-translational modi­fication of fibrinogen by reactive nitrogen species species. J Biol Chem. 2004;279:8820–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Nowak P, Kolodrziejczyk J, Wachowicz B. Peroxynitrite and fibrinolytic system: the effect of peroxynitrite on plasmin activity. Mol Cell Biochem. 2004;267:141–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Plane F, Bruckdorfer KR, Kerr P, Steuer A, Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 1992;105:216–22.PubMedGoogle Scholar
  14. 14.
    Watson SP, McConnell RT, Lapetina EG. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid. Biochem J. 1985;232:61–6.PubMedGoogle Scholar
  15. 15.
    Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem. 2000;275:28240–5.PubMedGoogle Scholar
  16. 16.
    Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid oxidation. Prog Lipid Res. 1997;36:1–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Mabile L, Bruckdorfer KR, Rice-Evans C. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. Atheros­clerosis. 1999;147:177–85.PubMedCrossRefGoogle Scholar
  18. 18.
    Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis. 1990;82:185–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Lehtimäki T, Lehtinen S, Solakivi T, et al. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol. 1999;19:23–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Miller 3rd ER, Erlinger TP, Sacks FM, et al. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis. 2005;183:175–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Heitzer T, Ylä Herttuala S, Wild E, Luoma J, Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J Am Coll Cardiol. 1999;33:499–505.PubMedCrossRefGoogle Scholar
  22. 22.
    Vasdev S, Gill VD, Singal PK. Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants. Exp Clin Cardiol. 2006;11:206–16.PubMedGoogle Scholar
  23. 23.
    Podrez EA, Byzova TV, Febbraio M, et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med. 1997;13:1086–95.CrossRefGoogle Scholar
  24. 24.
    Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.PubMedCrossRefGoogle Scholar
  25. 25.
    Rimm EB, Ascherio A, Giovannucci E, et al. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. J Am Med Assoc. 1996;275:447–51.CrossRefGoogle Scholar
  26. 26.
    Thorogood M. Do vegetables and fruit protect against coronary heart disease? Studies among vegetarians. In Preventing coronary Heart Disease: The role of antioxidants, vegetables and fruit. 1997 (Eds, Forum. NH). The Stationery Office, London.Google Scholar
  27. 27.
    Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ishemic stroke. JAMA. 1999;282:1233–9.PubMedCrossRefGoogle Scholar
  28. 28.
    De Lorgeril M, Salen P, Martin JL, et al. Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch Intern Med. 1998;158:1181–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24.PubMedCrossRefGoogle Scholar
  30. 30.
    Jenkins DJ, Popovich DG, Kendall CW, et al. Effect of a diet high in vegetables, fruit, and nuts on serum lipids. Metabolism. 1997;46:530–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Dauchet L, Amouyel P, Hercberg S, Dallongville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2007;136:2588–93.Google Scholar
  32. 32.
    Dauchet L, Amouyel P, Dollongeville P. Fruits vegetables and coronary heart disease. Nat Rev Cardiol. 2009;6:599–608.PubMedCrossRefGoogle Scholar
  33. 33.
    Beaglehole R, Jackson R, Watkinson J, Scragg R, Yee RL. Decreased blood selenium and risk of myocardial infarction. Int J Epidemiol. 1990;19:918–22.PubMedCrossRefGoogle Scholar
  34. 34.
    Riemersma RA, Oliver M, Elton RA, et al. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur J Clin Nutr. 1990;44:143–50.PubMedGoogle Scholar
  35. 35.
    Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Khaw KT, Bingham S, Welch A, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet. 2001;357:657–63.PubMedCrossRefGoogle Scholar
  38. 38.
    Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334:1156–62.PubMedCrossRefGoogle Scholar
  39. 39.
    Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000;72:476–83.PubMedGoogle Scholar
  40. 40.
    Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol. 1999;149:943–9.PubMedGoogle Scholar
  41. 41.
    Navarro-Alarcon M, Lopez-Garcia de la Serrana H, Perez-Valero V, Lopez-Martinez C. Serum and urine selenium concentrations in patients with cardiovascular diseases and relationship to other nutritional indexes. Ann Nutr Metab. 1999;43:30–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 1996;3:42–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Boekholdt SM, Hack SE, Sandhu MS, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993–2003. Atherosclerosis. 2006;187:415–22.PubMedCrossRefGoogle Scholar
  44. 44.
    Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83:567–74.PubMedGoogle Scholar
  45. 45.
    Jacobs M, Plane F, Bruckdorfer KR. Native and oxidised LDL have differential inhibitory effects on endothelium derived relaxing factor in rabbit aorta. Br J Pharmacol. 1990;100:21–6.PubMedGoogle Scholar
  46. 46.
    Heller R, Munscher-Paulig F, Grabner R, Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem. 1999;19:8254–60.CrossRefGoogle Scholar
  47. 47.
    Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617–22.PubMedGoogle Scholar
  48. 48.
    Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23–33.CrossRefGoogle Scholar
  49. 49.
    GISSI-Prevenzione Investigators. Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: results from the GISSI-prevenzione trial. Lancet. 1999;354:447–55.CrossRefGoogle Scholar
  50. 50.
    Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–35.CrossRefGoogle Scholar
  51. 51.
    Tornwall ME, Virtamo J, Haukka JK, Albanes D, Huttunen JK. Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. Atherosclerosis. 2001;157:167–73.PubMedCrossRefGoogle Scholar
  52. 52.
    Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol. 2000;20:230–5.PubMedCrossRefGoogle Scholar
  53. 53.
    Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Willcox B, Curb JD, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol. 2008;101(suppl):75D–86.PubMedCrossRefGoogle Scholar
  56. 56.
    Clarke R, Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Cardiovasc Drugs Ther. 2002;5:411–5.CrossRefGoogle Scholar
  57. 57.
    Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002;359:1108–13.PubMedCrossRefGoogle Scholar
  58. 58.
    Katsiki N, Manes C. Is there a role for supplemented antioxidants in the prevention of atherosclerosis? Clin Nutr. 2009;28:3–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Leonard JA, Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med. 2000;47:1673–706.Google Scholar
  60. 60.
    Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet. 2004;363:1724–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Tunstall-Pedoe H, Woodward M, SIGN Group on Risk Estimation. By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart. 2006;92:307–10.PubMedCrossRefGoogle Scholar
  62. 62.
    Wrieden WL, Hannah MK, Bolton-Smith C, Tavendale R, Morrison C, Tunstall-Pedoe H. Plasma vitamin C and food choice in the third Glasgow MONICA population survey. J Epidemiol Community Health. 2000;54:355–60.PubMedCrossRefGoogle Scholar
  63. 63.
    Fletcher AE, Breeze E, Shetty PS. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am J Clin Nutr. 2003;78:999–1010.PubMedGoogle Scholar
  64. 64.
    Timpson NJ, Forouhi NG, Brion MJ, et al. Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am J Clin Nutr. 2010;92:375–82.PubMedCrossRefGoogle Scholar
  65. 65.
    Upston JM, Terentis AC, Morris K, Keaney Jr JF, Stocker R. Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. Biochem J. 2002;363:753–60.PubMedCrossRefGoogle Scholar
  66. 66.
    Meuwese MC, Stroes ESG, Hazen SL. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals. J Am Coll Cardiol. 2007;50:159–65.PubMedCrossRefGoogle Scholar
  67. 67.
    Sies H, Sharov VS, Klotz LO, Briviba K, Sies H, Sharov VS, et al. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem. 1997;272:27812–7.PubMedCrossRefGoogle Scholar
  68. 68.
    Sabetkar M, Low SY, Naseem KM, Bruckdorfer KR. The nitration of proteins in platelets: significance in platelet function. Free Radic Biol Med. 2002;33:728–36.PubMedCrossRefGoogle Scholar
  69. 69.
    Shukla A, Rasik AM, Shankar R. Nitric oxide inhibits wound collagen biosynthesis. Mol Cell Biochem. 1999;200:27–33.PubMedCrossRefGoogle Scholar
  70. 70.
    Dooley A, Gao B, Shi-Wen X, Abraham DJ, Black CM, Jacobs M, et al. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts. Free Radic Biol Med. 2007;43:253–64.PubMedCrossRefGoogle Scholar
  71. 71.
    Sies H. Polyphenols and health: update and perspectives. Arch Biochem Biophys. 2010;501:2–5.PubMedCrossRefGoogle Scholar
  72. 72.
    Siow RC, Li FY, Rowlands DJ, de Winter P, Mann GE. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med. 2007;42:909–25.PubMedCrossRefGoogle Scholar
  73. 73.
    Khassaf M, McArdle A, Esanu C, et al. Effect of vitamin C supplements on antioxidant defence and stress proteins in human lymphocytes and skeletal muscle. J Physiol. 2003;549:645–52.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Structural and Molecular Biology, Faculty of Life SciencesUniversity College LondonLondonUK

Personalised recommendations